Director Declaration
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your GDR notes
genedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, announces that on 4 January 2024, Cytox Limited, a company which Dr. Ian Gilham, the Company's Non-Executive Chairman, was previously a Director of, appointed a liquidator in connection with a creditors voluntary winding up. No notice of administrators' proposal has yet been filed although the business was estimated to have a deficiency as regards creditors of £257,405.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.